首页> 美国卫生研究院文献>Current Controlled Trials in Cardiovascular Medicine >This is a platform alteration: a trial management perspective on the operational aspects of adaptive and platform and umbrella protocols
【2h】

This is a platform alteration: a trial management perspective on the operational aspects of adaptive and platform and umbrella protocols

机译:这是一个平台变更:关于自适应平台和保护伞协议的操作方面的试用管理观点

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundThere are limited research and literature on the trial management challenges encountered in running adaptive platform trials. This trial design allows both (1) the seamless addition of new research comparisons when compelling clinical and scientific research questions emerge, and (2) early stopping of accrual to individual comparisons that do not show sufficient activity without affecting other active comparisons. Adaptive platform design trials also offer many potential benefits over traditional trials, from faster time to accrual to contemporaneously recruiting multiple research comparisons, added flexibility to focus on more promising research comparisons via pre-planned interim analyses and potentially shorter time to primary results. We share here our experiences from a trial management perspective, highlighting the challenges and successes.
机译:背景技术关于在运行自适应平台试验中遇到的试验管理挑战的研究和文献有限。该试验设计既允许(1)在出现令人信服的临床和科学研究问题时无缝添加新的研究比较,也可以(2)尽早停止对不显示足够活动性而不影响其他有效比较的个体比较的应计。适应性平台设计试验还比传统试验具有许多潜在的好处,从缩短时间到应计到同时招募多个研究比较,通过预先计划的中期分析增加了灵活性,可专注于更有希望的研究比较,并且可能缩短获得主要结果的时间。我们从审判管理的角度分享我们的经验,重点介绍挑战和成功。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号